GlassScriptPhysician profile
Morgan Lough
NPI 1760974539
$647.46
in general payments reported to CMS, 2019-2025
19 companies · $37.14 in 2025
The $37.14 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.66 · 2020: $114 · 2021: $12.29 · 2022: $128 · 2023: $221 · 2024: $39.37 · 2025: $37.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $297.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $113.71 | 2022 | |
| Hologic Sales and Service, LLC | $111.87 | 2020-2023 | Fetal Fibronectin Enzyme Immunoassay |
| Lsi Solutions INC | $84.71 | 2023 | Fornisee |
| Bayer Healthcare Pharmaceuticals INC. | $48.29 | 2023 | |
| Minerva Surgical, INC | $35.62 | 2023-2025 | |
| Clovis Oncology, INC. | $26.20 | 2019 | |
| Verastem, INC. | $24.17 | 2019 | |
| Astellas Pharma US INC | $23.77 | 2024 | Veozah |
| Exeltis, USA INC. | $21.81 | 2023 | Slynd |
| Roche Diagnostics Corporation | $19.79 | 2020 | |
| Sumitomo Pharma America, INC. | $18.48 | 2023 | Myfembree |
| Taiho Oncology, INC. | $17.82 | 2019 | |
| Organon LLC | $17.17 | 2023 | Nexplanon |
| Aspira Women'S Health INC | $15.60 | 2024 | Ova1 |
| Solventum Corporation | $15.13 | 2025 | V.A.C. Granufoam, Prevena, Activ.A.C. |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tesaro, INC. | $14.59 | 2019 | |
| Morphosys, US INC. | $14.56 | 2022 | |
| Conmed Corporation | $12.29 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $11.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Lough listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.